0001853816 EX-FILING FEES 0001853816 2026-01-22 2026-01-22 0001853816 1 2026-01-22 2026-01-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

EXHIBIT 107

 

Calculation of Filing Fee Tables

 

Form S-3

(Form Type)

 

Dermata Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

  

Security

Type

 

Security

Class Title

 

Fee

Calculation

or Carry

Forward

Rule

 

Amount

Registered (1)

  

Proposed

Maximum

Offering

Price Per

Unit (2)

  

Maximum

Aggregate

Offering

Price (1)

   Fee Rate  

Amount of

Registration

Fee

 
Fees to Be Paid  Equity  Common Stock, par value $0.0001 per share  Other   6,207,730   $

2.08

   $12,912,078.40    0.00013810   $

1,783.16

 
   Total Offering Amounts            $12,912,078.40         $

1,783.16

 
   Total Fees Previously Paid                      $0 
   Total Fee Offsets                      $0 
   Net Fee Due                      $

1,783.16

 

 

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate number of additional common shares as may be issued or issuable because of stock splits, stock dividends stock distributions, and similar transactions.
   
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act based on a per share price of $2.08, the average of the high $2.15 and low $2.01 reported sales prices of the registrant’s common stock on the Nasdaq Capital Market on January 21, 2026.